UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325
Home » Archive of numbers » 2024 » Volume 32, issue 3 (120) » EFFECTIVENESS OF IMPROVING THE QUALITY OF LIFE IN PATIENTS WITH SARCOPENIA THROUGH LIFESTYLE MODIFICATION WITH MEDICAL-PSYCHOLOGICAL CORRECTION

EFFECTIVENESS OF IMPROVING THE QUALITY OF LIFE IN PATIENTS WITH SARCOPENIA THROUGH LIFESTYLE MODIFICATION WITH MEDICAL-PSYCHOLOGICAL CORRECTION

Authors

Type of Article

  • Scientific Article

In the Section

  • DIAGNOSTICS AND THERAPY OF MENTAL AND BEHAVIORAL DISORDERS

Key words

Index UDK:
  • 616.74-08:159.96:364.12

Abstract

  • Purpose: To determine the effectiveness of the lifestyle modification program, designed to improve the quality of life in patients with sarcopenia, which developed against the background of stage III—IV malignant solid tumors. Contingents and methods: 80 patients with stage III—IV malignant neoplasms and sarcopenia treated at the "ONCOLIFE" medical center (Zaporizhzhia) took part in the study. Patients were randomly divided into two equal groups of 40 patients each. Group 1 (G1) received complex treatment, which, in addition to standard chemotherapy protocols, included lifestyle modification; group 2 (G2) received standard oncology treatment according to protocols. Quality of life was assessed using the SarQoL (Sarcopenia and Quality of Life) questionnaire. Determination of the quality of life in patients with sarcopenia was carried out before the start of treatment and thereafter every month for 6 months. The lifestyle modification program, designed for patients with sarcopenia, which developed against the background of stage III—IV malignant solid tumors, leads to statistically significant improvement in the quality of life in all domains and in the total score. The greatest improvement in the quality of life was achieved in the following domains: physical and mental health, leisure activities, and fear. Indicators of general quality of life, physical and mental health, and body composition showed slow growth in the first months of complex therapy, and rapid growth in the last months. In the domain of mobility and functionality, a smooth and uniform increase in quality of life was noted throughout the treatment period. In the domains of daily activities and leisure activities, there was a slow increase in the quality of life at the beginning and at the end of the treatment, and its rapid increase in the middle of the therapeutic process. The fear domain showed rapid increase in quality of life at the beginning of therapy, with a subsequent slowdown.

Pages

  • 46-49

Year / Issue

Download PDF

Bibliography

1. Dhillon RJ, Hasni S. Pathogenesis and  Managementof Sarcopenia. Clin Geriatr Med. 2017 Feb;33(1):17-26. doi: 10.1016/j.cger.2016.08.002. PMID: 27886695; PMCID:PMC5127276.
2. Fernandes LV, Paiva AEG, Silva ACB, de Castro IC, Santiago  AF, de  Oliveira EP, et  al. Prevalence of  sarcopenia according to EWGSOP1 and EWGSOP2 in older adults and theirassociations with unfavorable health outcomes: a systematicreview. Aging Clin Exp Res. 2022;34(3):505-514. doi: 10.1007/s40520-021-01951-7. PMID: 34398438.
3. Anjanappa M, Corden M, Green A, Roberts D, Hoskin P,McWilliam A, Choudhury A. Sarcopenia in  cancer: Riskingmore than muscle loss. Tech Innov Patient Support RadiatOncol. 2020 Nov 9;16:50-57. doi: 10.1016/j.tipsro.2020.10.001.PMID: 33385074; PMCID: PMC7769854.
4. Petermann-Rocha F, Balntzi V, Gray SR, Lara J, Ho  FK,Pell  JP, Celis-Morales  C. Global prevalence of  sarcopeniaand severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022;13(1):86-99. doi: 10.1002/jcsm.12783. PMID: 34816624 PMCID: PMC8818604.
5. Naser AY, Hameed AN, Mustafa N, Alwafi H, Dahmash EZ,Alyami HS, Khalil H. Depression and Anxiety in Patients withCancer: a cross-sectional study. Front Psychol. 2021 Apr 15;12:585534. doi: 10.3389/fpsyg.2021.585534. PMID: 33935849;PMCID: PMC8081978.
6. Zhang AY, Ganocy SJ. Measurement of irritability in cancerpatients. Nurs Res. 2020 Mar/Apr;69(2): 91-99. doi: 10.1097/NNR.0000000000000411. PMID: 31764606; PMCID: PMC7050421.
7. Hammermüller, C., Hinz A, Dietz A, Wichmann G, Pirlich M,Berger T, Zimmermann K, Neumuth T, Mehnert-Theuerkauf A,Wiegand S, Zebralla V. Depression, anxiety, fatigue, and quality of life in a large sample of patients suffering from headand neck cancer in comparison with the general population.BMC cancer. 2021 Jan 22;21(1):94. doi: 10.1186/s12885-020-07773-6. PMID: 33482771; PMCID: PMC7825198.
8. Nipp RD, Fuchs G, El-Jawahri A, Mario J, Troschel FM,Greer JA, Gallagher ER, Jackson VA, Kambadakone A, Hong TS,Temel JS, Fintelmann FJ. Sarcopenia Is Associated with Qualityof  Life and  Depression in  Patients with Advanced Cancer.Oncologist. 2018 Jan;23(1):97-104. doi: 10.1634/theoncologist.2017-0255. Epub 2017 Sep 21. PMID: 28935775; PMCID:PMC5759817.
9. Zhao H, Cheng R, Song G, Teng J, Shen S, Fu X, Yan Y,Liu C. The  Effect of  Resistance Training on  the Rehabilitation of  Elderly Patients with Sarcopenia: A  Meta-Analysis.Int J Environ Res Public Health. 2022 Nov 22;19(23):15491. PMID:36497565. PMCID: PMC9739568. doi: 10.3390/ijerph192315491.PMID: 36497565; PMCID: PMC9739568.
10. Coll PP, Phu  S, Hajjar SH, Kirk B, Duque G, Taxel  P.The prevention of osteoporosis and sarcopenia in older adults.J Am Geriatr Soc. 2021 May;69(5):1388-1398. PMID: 33624287.doi: 10.1111/jgs.17043. Epub 2021 Feb 23. PMID: 33624287.

Journal’s Indexing:

UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine

ДУ «ІНПН імені
П.В. ВОЛОШИНА
НАМН УКРАЇНИ»